Business Context and Reporting Period
Company: Bleichroeder Acquisition Corp. II (BBCQ)
Filing Date: February 28, 2026 (Report Date: March 4, 2026)
Event: Entry into a Material Definitive Agreement (Business Combination Agreement) with Pasqal Holding SAS, a French quantum computing company. The transaction involves a reincorporation merger followed by a merger by absorption, resulting in a new entity named "Pasqal Holding SA" (New Pasqal).
Expected Closing: Second half of 2026, subject to regulatory and shareholder approvals.
Key Financial Metrics and Transaction Terms
- Valuation: Pasqal is valued at $2.0 billion pre-money.
- Private Placement (PIPE): Investors agreed to purchase $250 million aggregate principal amount of senior unsecured convertible bonds and warrants for an aggregate purchase price of $200 million (reflecting a 20% original issue discount).
- Debt Instrument Terms:
- Interest Rate: 10.0% per annum payable in cash semi-annually. If cash payment is missed, it converts to Payment-in-Kind (PIK) at 12% compounded annually.
- Conversion Price: Initially $12.00 per share, subject to anti-dilution adjustments.
- Ranking: Senior to New Pasqal shares; junior to other unsecured unsubordinated obligations.
- Liquidity Requirement: Closing is conditioned on at least $150,000,000 cash available to New Pasqal from the Trust Account (post-redemptions), PIPE proceeds, and other financing.
- Warrant Terms: Investment Warrants are exercisable at $12.00 per share and expire five years post-closing. Existing Bleichroeder warrants convert to New Pasqal warrants.
Material Changes and Transaction Structure
The filing represents a material change in the company's status from a Special Purpose Acquisition Company (SPAC) to a combined operating entity with Pasqal.
- Share Conversion: Existing Bleichroeder Class A and Class B ordinary shares convert 1:1 into New Pasqal shares. Redeeming shares are cancelled for a pro rata share of the Trust Account.
- Unit Separation: Outstanding units automatically detach into one Class A share and one-third of one warrant prior to the merger.
- Board Composition: The initial board of New Pasqal will consist of nine directors, including five French or European citizens/non-US residents. Key appointments include Alain Aspect (Non-Executive Chairman) and Wasiq Bokhari (CEO).
- Lock-Up: Lock-Up Parties are restricted from selling shares for 180 days post-closing or until the share price exceeds $12.00 for 20 trading days within a 30-day period.
Guidance, Risks, and Contingencies
Conditions to Closing: The transaction is subject to customary conditions, including SEC effectiveness of the Registration Statement/Proxy Statement, shareholder approvals, Nasdaq listing approval, and the absence of a Material Adverse Effect.
Termination Rights:
- The agreement may be terminated if closing does not occur by December 31, 2026 (Outside Date), though this date automatically extends to December 31, 2027, unless both parties agree to terminate.
- Additional 60-day extensions apply if SEC or antitrust approvals are delayed.
- Liquidated Damages: If Bleichroeder terminates due to Pasqal's failure to deliver PCAOB Financials by September 30, 2026, or for breach of agreement, Pasqal must pay Bleichroeder $3,000,000.
Risks and Uncertainties:
- Redemption Risk: High redemption rates by Bleichroeder shareholders could leave the combined company with insufficient cash.
- Regulatory Risk: Failure to obtain antitrust or other governmental approvals.
- Operational Risk: Pasqal's reliance on emerging quantum technology, limited operating history, and concentration of revenue in government contracts.
- Debt Risk: The 10% interest rate and potential PIK interest could strain liquidity if cash flows are insufficient.
Investor Verification Checklist
- Redemption Levels: Verify the final number of shares redeemed by Bleichroeder shareholders to confirm the $150 million cash condition is met.
- PCAOB Financials: Confirm Pasqal delivers audited financial statements by the September 30, 2026 deadline to avoid termination and liquidated damages.
- Regulatory Approvals: Monitor the status of antitrust reviews and SEC effectiveness of the Form F-4 Registration Statement.
- Debt Covenants: Review the specific protective provisions in the Senior Unsecured Convertible Bonds, particularly restrictions on dividends, new debt, and affiliate transactions.
- Shareholder Approval: Track the voting results for the Business Combination at the upcoming shareholder meeting.